BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33499230)

  • 1. Receptor for Advanced Glycation End Products Is Involved in LPA
    Sapkota A; Park SJ; Choi JW
    Life (Basel); 2021 Jan; 11(2):. PubMed ID: 33499230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic Acid Receptor 5 Plays a Pathogenic Role in Brain Damage after Focal Cerebral Ischemia by Modulating Neuroinflammatory Responses.
    Sapkota A; Lee CH; Park SJ; Choi JW
    Cells; 2020 Jun; 9(6):. PubMed ID: 32532027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of LPA
    Sapkota A; Park SJ; Choi JW
    Biomol Ther (Seoul); 2020 Nov; 28(6):512-518. PubMed ID: 33024060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 Inflammasome Activation Is Involved in LPA
    Lee CH; Sapkota A; Gaire BP; Choi JW
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions through NLRP3 Inflammasome Activation in Macrophages.
    Gaire BP; Lee CH; Kim W; Sapkota A; Lee DY; Choi JW
    Cells; 2020 Jul; 9(8):. PubMed ID: 32707926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acid receptor 1 (LPA
    Gaire BP; Sapkota A; Song MR; Choi JW
    J Neuroinflammation; 2019 Aug; 16(1):170. PubMed ID: 31429777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine 1-phosphate receptor subtype 3 (S1P
    Gaire BP; Song MR; Choi JW
    J Neuroinflammation; 2018 Oct; 15(1):284. PubMed ID: 30305119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S1P
    Gaire BP; Bae YJ; Choi JW
    Biomol Ther (Seoul); 2019 Nov; 27(6):522-529. PubMed ID: 31181588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic Acid Receptor 1 Plays a Pathogenic Role in Permanent Brain Ischemic Stroke by Modulating Neuroinflammatory Responses.
    Tiwari S; Basnet N; Choi JW
    Biomol Ther (Seoul); 2024 May; 32(3):319-328. PubMed ID: 38627097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAGE-NF-κB-PPARγ Signaling is Involved in AGEs-Induced Upregulation of Amyloid-β Influx Transport in an In Vitro BBB Model.
    Chen F; Ghosh A; Hu M; Long Y; Sun H; Kong L; Hong H; Tang S
    Neurotox Res; 2018 Feb; 33(2):284-299. PubMed ID: 28871412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMS-986020, a Specific LPA
    Gaire BP; Sapkota A; Choi JW
    Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33171697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of RAGE isoforms expression in the brain and plasma of rats exposed to transient focal cerebral ischemia.
    Greco R; Amantea D; Mangione AS; Petrelli F; Gentile R; Nappi G; Blandini F; Corasaniti MT; Tassorelli C
    Neurochem Res; 2012 Jul; 37(7):1508-16. PubMed ID: 22528836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for advanced glycation end-product antagonist reduces blood-brain barrier damage after intracerebral hemorrhage.
    Yang F; Wang Z; Zhang JH; Tang J; Liu X; Tan L; Huang QY; Feng H
    Stroke; 2015 May; 46(5):1328-36. PubMed ID: 25782468
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Ko G; Kim J; Jeon YJ; Lee D; Baek HM; Chang KA
    Antioxidants (Basel); 2023 Mar; 12(4):. PubMed ID: 37107160
    [No Abstract]   [Full Text] [Related]  

  • 15. S1P
    Sapkota A; Gaire BP; Kang MG; Choi JW
    Sci Rep; 2019 Aug; 9(1):12106. PubMed ID: 31431671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
    Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
    Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cerebral RAGE expression following nitric oxide synthase inhibition in rats subjected to focal cerebral ischemia.
    Greco R; Demartini C; Zanaboni AM; Blandini F; Amantea D; Tassorelli C
    Eur J Pharmacol; 2017 Apr; 800():16-22. PubMed ID: 28188764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effect of Smilax glabra extract on advanced glycation end products-induced endothelial dysfunction in HUVECs via RAGE-ERK1/2-NF-κB pathway.
    Sang HQ; Gu JF; Yuan JR; Zhang MH; Jia XB; Feng L
    J Ethnopharmacol; 2014 Aug; 155(1):785-95. PubMed ID: 24953033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P
    Gaire BP; Lee CH; Sapkota A; Lee SY; Chun J; Cho HJ; Nam TG; Choi JW
    Mol Neurobiol; 2018 Mar; 55(3):2320-2332. PubMed ID: 28343295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.